Molecular mechanisms of the juvenile form of Batten disease: important role of MAPK signaling pathways (ERK1/ERK2, JNK and p38) in pathogenesis of the malady

Abstract Background Mutations in the CLN3 gene lead to so far an incurable juvenile-onset neuronal ceroid lipofuscinosis (JNCL) or Batten disease that starts at the age of 4–6 years with a progressive retinopathy leading to blindness. Motor disturbances, epilepsy and dementia manifest during several...

Full description

Bibliographic Details
Main Authors: Elena K. Shematorova, Dmitry G. Shpakovski, Anna D. Chernysheva, George V. Shpakovski
Format: Article
Language:English
Published: BMC 2018-09-01
Series:Biology Direct
Subjects:
Online Access:http://link.springer.com/article/10.1186/s13062-018-0212-y
_version_ 1818451306729177088
author Elena K. Shematorova
Dmitry G. Shpakovski
Anna D. Chernysheva
George V. Shpakovski
author_facet Elena K. Shematorova
Dmitry G. Shpakovski
Anna D. Chernysheva
George V. Shpakovski
author_sort Elena K. Shematorova
collection DOAJ
description Abstract Background Mutations in the CLN3 gene lead to so far an incurable juvenile-onset neuronal ceroid lipofuscinosis (JNCL) or Batten disease that starts at the age of 4–6 years with a progressive retinopathy leading to blindness. Motor disturbances, epilepsy and dementia manifest during several following years. Most JNCL patients carry the same 1.02-kb deletion in the CLN3 gene, encoding an unusual transmembrane protein, CLN3 or battenin. Results Based on data of genome-wide expression profiling in CLN3 patients with different rate of the disease progression [Mol. Med., 2011, 17: 1253–1261] and our bioinformatic analysis of battenin protein-protein interactions in neurons we propose that CLN3 can function as a molecular chaperone for some plasma membrane proteins, being crucially important for their correct folding in endoplasmic reticulum. Changes in spatial structure of these membrane proteins lead to transactivation of the located nearby receptors. Particularly, CLN3 interacts with a subunit of Na/K ATPase ATP1A1 which changes its conformation and activates the adjacent epidermal growth factor receptor (EGFR). As a result, a large amount of erroneously activated EGFR generates MAPK signal cascades (ERK1/ERK2, JNKs and p38) from cell surface eventually causing neurons’ death. Conclusions Molecular mechanism of the juvenile form of Batten disease (JNCL), which is based on the excessive activation of signaling cascades in a time of the radical increase of neuronal membranes’ area in the growing brain, have been proposed and substantiated. The primary cause of this phenomenon is the defective function of the CLN3 protein that could not act properly as molecular chaperone for some plasma membrane proteins in the endoplasmic reticulum. The incorrect three-dimensional structure of at least one such protein, ATP1A1, leads to unregulated spontaneous and repetitive activation of the SRC kinase that transactivates EGFR with the subsequent uncontrolled launch of various MAPK cascades. Possible ways of treatment of patients with JNCL have been suggested. Reviewers This article was reviewed by Konstantinos Lefkimmiatis, Eugene Koonin and Vladimir Poroikov.
first_indexed 2024-12-14T21:05:06Z
format Article
id doaj.art-f78a10a255d44a4393fb15e8319a415d
institution Directory Open Access Journal
issn 1745-6150
language English
last_indexed 2024-12-14T21:05:06Z
publishDate 2018-09-01
publisher BMC
record_format Article
series Biology Direct
spelling doaj.art-f78a10a255d44a4393fb15e8319a415d2022-12-21T22:47:30ZengBMCBiology Direct1745-61502018-09-011311910.1186/s13062-018-0212-yMolecular mechanisms of the juvenile form of Batten disease: important role of MAPK signaling pathways (ERK1/ERK2, JNK and p38) in pathogenesis of the maladyElena K. Shematorova0Dmitry G. Shpakovski1Anna D. Chernysheva2George V. Shpakovski3Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of SciencesShemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of SciencesShemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of SciencesShemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of SciencesAbstract Background Mutations in the CLN3 gene lead to so far an incurable juvenile-onset neuronal ceroid lipofuscinosis (JNCL) or Batten disease that starts at the age of 4–6 years with a progressive retinopathy leading to blindness. Motor disturbances, epilepsy and dementia manifest during several following years. Most JNCL patients carry the same 1.02-kb deletion in the CLN3 gene, encoding an unusual transmembrane protein, CLN3 or battenin. Results Based on data of genome-wide expression profiling in CLN3 patients with different rate of the disease progression [Mol. Med., 2011, 17: 1253–1261] and our bioinformatic analysis of battenin protein-protein interactions in neurons we propose that CLN3 can function as a molecular chaperone for some plasma membrane proteins, being crucially important for their correct folding in endoplasmic reticulum. Changes in spatial structure of these membrane proteins lead to transactivation of the located nearby receptors. Particularly, CLN3 interacts with a subunit of Na/K ATPase ATP1A1 which changes its conformation and activates the adjacent epidermal growth factor receptor (EGFR). As a result, a large amount of erroneously activated EGFR generates MAPK signal cascades (ERK1/ERK2, JNKs and p38) from cell surface eventually causing neurons’ death. Conclusions Molecular mechanism of the juvenile form of Batten disease (JNCL), which is based on the excessive activation of signaling cascades in a time of the radical increase of neuronal membranes’ area in the growing brain, have been proposed and substantiated. The primary cause of this phenomenon is the defective function of the CLN3 protein that could not act properly as molecular chaperone for some plasma membrane proteins in the endoplasmic reticulum. The incorrect three-dimensional structure of at least one such protein, ATP1A1, leads to unregulated spontaneous and repetitive activation of the SRC kinase that transactivates EGFR with the subsequent uncontrolled launch of various MAPK cascades. Possible ways of treatment of patients with JNCL have been suggested. Reviewers This article was reviewed by Konstantinos Lefkimmiatis, Eugene Koonin and Vladimir Poroikov.http://link.springer.com/article/10.1186/s13062-018-0212-yJuvenile neuronal ceroid lipofuscinosis (Batten disease)CLN3Molecular chaperoneATP1A1SRCEGFR
spellingShingle Elena K. Shematorova
Dmitry G. Shpakovski
Anna D. Chernysheva
George V. Shpakovski
Molecular mechanisms of the juvenile form of Batten disease: important role of MAPK signaling pathways (ERK1/ERK2, JNK and p38) in pathogenesis of the malady
Biology Direct
Juvenile neuronal ceroid lipofuscinosis (Batten disease)
CLN3
Molecular chaperone
ATP1A1
SRC
EGFR
title Molecular mechanisms of the juvenile form of Batten disease: important role of MAPK signaling pathways (ERK1/ERK2, JNK and p38) in pathogenesis of the malady
title_full Molecular mechanisms of the juvenile form of Batten disease: important role of MAPK signaling pathways (ERK1/ERK2, JNK and p38) in pathogenesis of the malady
title_fullStr Molecular mechanisms of the juvenile form of Batten disease: important role of MAPK signaling pathways (ERK1/ERK2, JNK and p38) in pathogenesis of the malady
title_full_unstemmed Molecular mechanisms of the juvenile form of Batten disease: important role of MAPK signaling pathways (ERK1/ERK2, JNK and p38) in pathogenesis of the malady
title_short Molecular mechanisms of the juvenile form of Batten disease: important role of MAPK signaling pathways (ERK1/ERK2, JNK and p38) in pathogenesis of the malady
title_sort molecular mechanisms of the juvenile form of batten disease important role of mapk signaling pathways erk1 erk2 jnk and p38 in pathogenesis of the malady
topic Juvenile neuronal ceroid lipofuscinosis (Batten disease)
CLN3
Molecular chaperone
ATP1A1
SRC
EGFR
url http://link.springer.com/article/10.1186/s13062-018-0212-y
work_keys_str_mv AT elenakshematorova molecularmechanismsofthejuvenileformofbattendiseaseimportantroleofmapksignalingpathwayserk1erk2jnkandp38inpathogenesisofthemalady
AT dmitrygshpakovski molecularmechanismsofthejuvenileformofbattendiseaseimportantroleofmapksignalingpathwayserk1erk2jnkandp38inpathogenesisofthemalady
AT annadchernysheva molecularmechanismsofthejuvenileformofbattendiseaseimportantroleofmapksignalingpathwayserk1erk2jnkandp38inpathogenesisofthemalady
AT georgevshpakovski molecularmechanismsofthejuvenileformofbattendiseaseimportantroleofmapksignalingpathwayserk1erk2jnkandp38inpathogenesisofthemalady